Time-of-day determines neuronal damage and mortality after cardiac arrest

Neurobiology of Disease

Volumn 36, Issue 2, 2009, Pages 352-360

  Weil, Zachary M ^a   Karelina, Kate ^a   Su, Alan J ^a   Barker, Jacqueline M ^a   Norman, Greg J ^a   Zhang, Ning ^a   DeVries, A Courtney ^a   Nelson, Randy J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cardiac arrest; Circadian rhythms; Global ischemia; Heart disease; Microglia; Proinflammatory cytokines

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART ARREST; HIPPOCAMPUS; LOCOMOTION; MALE; MICROGLIA; MORTALITY; MOUSE; NERVE CELL LESION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; CELL DEATH; CIRCADIAN RHYTHM; HEART ARREST; MALE; MICE; MICE, INBRED C3H; NEURONS; SURVIVAL RATE; TIME FACTORS;

EID: 70349781648     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.032     Document Type: Article

References (60)

1. Abe M., et al. Circadian rhythms in isolated brain regions. J. Neurosci. 22 (2002) 350-356
2. Antolin I., et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10 (1996) 882-890
3. Bain R.J., et al. Serum cortisol levels predict infarct size and patient mortality. Int. J. Cardiol. 37 (1992) 145-150
4. Barlow-Walden L.R., et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26 (1995) 497-502
5. Becker L.B., et al. Outcome of CPR in a large metropolitan area-where are the survivors?. Ann. Emerg. Med. 20 (1991) 355-361
6. Bergeron L., and Yuan J. Sealing one's fate: control of cell death in neurons. Curr. Opin. Neurobiol. 8 (1998) 55-63
7. Cazevieille C., et al. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res. 768 (1997) 120-124
8. Chen J., et al. Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death. J. Cereb. Blood Flow Metab. 20 (2000) 1033-1039
9. Coggeshall R.E., and Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364 (1996) 6-15
10. Cohen M.C., et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am. J. Cardiol. 79 (1997)
11. Crawley J.N. What's Wrong with My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice (2000), Wiley-Liss, New York
12. Cuzzocrea S., and Reiter R.J. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur. J. Pharmacol. 426 (2001) 1-10
13. DeVries A.C., et al. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11824-11828
14. DeVries A.C., et al. Social modulation of stress responses. Physiol. Behav. 79 (2003) 399-407
15. DeVries A.C., et al. 2006 Curt P. Richter award winner: social influences on stress responses and health. Psychoneuroendocrinology 32 (2007) 587-603
16. Drazen D.L., et al. Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1476-R1482
17. Hayashi Y., et al. The intra-arterial injection of microglia protects hippocampal CA1 neurons against global ischemia-induced functional deficits in rats. Neuroscience 142 (2006) 87-96
18. Herzog E.D. Neurons and networks in daily rhythms. Nat. Rev., Neurosci. 8 (2007) 790-802
19. Ishiura M., et al. Expression of a gene cluster kaiABC as a circadian feedback process in Cyanobacteria. Science 281 (1998) 1519-1523
20. Jastremski M., et al. Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. JAMA 262 (1989) 3427-3430
21. Jiang Z.G., and North R.A. Membrane properties and synaptic responses of rat striatal neurones in vitro. J. Physiol. (London) 443 (1991) 533-553
22. Kilic E., et al. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 511-516
23. Kirino T., et al. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol. 64 (1984) 139-147
24. Kitagawa K., et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 29 (1998) 2616-2621
25. Kofler J., et al. Histopathological and behavioral characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice. J. Neurosci. Methods 136 (2004) 33-44
26. Krause G.S., et al. Ischemia, resuscitation, and reperfusion: mechanisms of tissue injury and prospects for protection. Am. Heart J. 111 (1986) 768-780
27. Letechipia-Vallejo G., et al. Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats. Arch. Med. Res. 32 (2001) 186-192
28. Liu L., and Yenari M. Therapeutic hypothermia: neuroprotective mechanisms. Front. Biosci. 12 (2007) 816-825
29. Manev H., et al. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J. 10 (1996) 1546-1551
30. Martinez-Vargas M., et al. Recovery after a traumatic brain injury depends on diurnal variations: effect of cystatin C. Neurosci. Lett. 400 (2006) 21-24
31. Martinou J.C., et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13 (1994) 1017-1030
32. Muller J.E., et al. Circadian variation in the frequency of sudden cardiac death. Circulation 75 (1987) 131-138
33. Neigh G.N., et al. Cardiac arrest/cardiopulmonary resuscitation increases anxiety-like behavior and decreases social interaction. J. Cereb. Blood Flow Metab. 24 (2004) 372-382
34. Overbergh L., et al. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11 (1999) 305-312
35. Pandi-Perumal S.R., et al. Melatonin: nature's most versatile biological signal?. FEBS J. 273 (2006) 2813-2838
36. Perez-Pinzon M.A. Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 147 (2007) 291-299
37. Poeggeler B. Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 27 (2005) 201-212
38. Poeggeler B., et al. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J. Pineal Res. 14 (1993) 151-168
39. Popovich P.G., et al. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377 (1997) 443-464
40. Portaluppi F., and Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv. Drug Deliv. Rev. 59 (2007) 952-965
41. Pulsinelli W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog. Brain Res. 63 (1985) 29-37
42. Reiter R.J., et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp. Biol. Med. (Maywood) 230 (2005) 104-117
43. Reppert S.M., and Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63 (2001) 647-676
44. Rocco M.B., et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 75 (1987) 395-400
45. Roine R.O., et al. Neuropsychological sequelae of cardiac arrest. JAMA 269 (1993) 237-242
46. Sapolsky R.M., and Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229 (1985) 1397-1400
47. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
48. Schmued L.C., and Hopkins K.J. Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28 (2000) 91-99
49. Stehle J.H., et al. Organisation of the circadian system in melatonin-proficient C3H and melatonin-deficient C57BL mice: a comparative investigation. Cell Tissue Res. 309 (2002) 173-182
50. Stokkan K.A., et al. Entrainment of the circadian clock in the liver by feeding. Science 291 (2001) 490-493
51. Stoll G., et al. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56 (1998) 149-171
52. Streit W.J., et al. Functional plasticity of microglia: a review. Glia 1 (1988) 301-307
53. Stubbs P.J., et al. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin. Sci. (Lond) 96 (1999) 589-595
54. Sun F.Y., et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J. Pineal Res. 33 (2002) 48-56
55. Thompson D.R., et al. Time of onset of chest pain in acute myocardial infarction. Int. J. Cardiol. 7 (1985) 139-148
56. Tischkau S.A., et al. Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. Exp. Neurol. 208 (2007) 314-322
57. Wang D., and Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res. 533 (1990) 78-82
58. Willich S.N., et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am. J. Cardiol 60 (1987) 801-806
59. Yrjanheikki J., et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15769-15774
60. Zhao H., et al. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J. Neurochem. 85 (2003) 1026-1036